Diagnosis and management of chronic myeloid leukemia: a survey of American and European practice patterns
HM Kantarjian, J Cortes, F Guilhot… - … Journal of the …, 2007 - Wiley Online Library
BACKGROUND. The success of imatinib therapy for chronic myeloid leukemia (CML) has
brought new challenges; these include optimizing disease monitoring, imatinib resistance …
brought new challenges; these include optimizing disease monitoring, imatinib resistance …
Current patient management of chronic myeloid leukemia in Latin America: a study by the Latin American Leukemia Net (LALNET)
BACKGROUND: Treatment recommendations have been developed for management of
patients with chronic myeloid leukemia (CML). METHODS: A 30‐item multiple‐choice …
patients with chronic myeloid leukemia (CML). METHODS: A 30‐item multiple‐choice …
Current perspectives on the treatment of patients with chronic myeloid leukemia: an individualized approach to treatment
E Jabbour, J Cortes, F Giles, H Kantarjian - The Cancer Journal, 2007 - journals.lww.com
Purpose: The BCR-ABL tyrosine kinase inhibitor imatinib has dramatically improved the
prognosis for most patients with chronic myeloid leukemia (CML). Efforts to optimize therapy …
prognosis for most patients with chronic myeloid leukemia (CML). Efforts to optimize therapy …
Treatment of chronic myeloid leukemia in the imatinib era: perspective from a developing country
BACKGROUND There is paucity of data from developing countries on the efficacy and safety
of imatinib mesylate in chronic myeloid leukemia (CML). The primary objective of this study …
of imatinib mesylate in chronic myeloid leukemia (CML). The primary objective of this study …
Improved survival in chronic myeloid leukemia since the introduction of imatinib therapy: a single-institution historical experience
H Kantarjian, S O'Brien, E Jabbour… - Blood, The Journal …, 2012 - ashpublications.org
A total of 1569 patients with chronic myeloid leukemia (CML) referred to our institution within
1 month of diagnosis since 1965 were reviewed: 1148 chronic phase (CP), 175 accelerated …
1 month of diagnosis since 1965 were reviewed: 1148 chronic phase (CP), 175 accelerated …
Imatinib therapy for chronic myeloid leukemia: where do we go now?
JE Cortes - Journal of clinical oncology: official journal of the …, 2008 - europepmc.org
Imatinib therapy for chronic myeloid leukemia: where do we go now? - Abstract - Europe PMC
Sign in | Create an account https://orcid.org Europe PMC Menu About Tools Developers Help …
Sign in | Create an account https://orcid.org Europe PMC Menu About Tools Developers Help …
Management of chronic myeloid leukaemia in clinical practice in France: results of the French subset of patients from the UNIC study
M Michallet, M Tulliez, S Corm… - … medical research and …, 2010 - Taylor & Francis
Objective: To assess real-life treatment practices with imatinib for chronic-phase chronic
myeloid leukaemia (CP-CML) in France. Research design and methods: In the …
myeloid leukaemia (CP-CML) in France. Research design and methods: In the …
Suboptimal response to or failure of imatinib treatment for chronic myeloid leukemia: what is the optimal strategy?
E Jabbour, JE Cortes, HM Kantarjian - Mayo Clinic Proceedings, 2009 - Elsevier
Treatment responses to imatinib vary among patients with chronic myeloid leukemia (CML),
and definitions of treatment failure and suboptimal response have been published. This …
and definitions of treatment failure and suboptimal response have been published. This …
Management of chronic myeloid leukemia in France: a multicentered cross‐sectional study on 538 patients
S Tardieu, C Brun‐Strang, P Berthaud… - … and drug safety, 2005 - Wiley Online Library
Purpose Little is known about the actual management and treatment of chronic myeloid
leukemia (CML) in clinical practice, although there have been many recent changes, such …
leukemia (CML) in clinical practice, although there have been many recent changes, such …
Diagnosis and treatment of chronic myeloid leukemia in the imatinib mesylate era: report of the experience at “La Raza” medical center in mexico
M Ayala, E Ávila, J Domínguez, X Aquino… - … Lymphoma Myeloma and …, 2016 - Elsevier
Background With the advent of tyrosine kinase inhibitors (TKIs), the prognosis of chronic
myeloid leukemia (CML) has undergone significant changes in all age groups and at …
myeloid leukemia (CML) has undergone significant changes in all age groups and at …